Results 41 to 50 of about 7,599 (254)

Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese non-diabetic subjects [PDF]

open access: yes, 2018
K
Fülöp, Péter   +5 more
core   +2 more sources

Paraoxonase 1 Activity and its Polymorphism in Type 2 Diabetic Nephropathy

open access: yesEndocrinology Research and Practice, 2018
Objective: This study aims to investigate the role of paraoxonase 1 activity and Q192R polymorphism in the development of nephropathy in patients with Type 2 diabetes mellitus.
Mukund R. MOGAREKAR   +2 more
doaj   +1 more source

Oxidative stress and peri-implantitis: The role of oxidants and antioxidants [PDF]

open access: yesJournal of Oral Health and Oral Epidemiology, 2023
Background: Peri-implantitis is the main cause of implant failure and is associated with augmented oxidative stress or tissue destruction. In this study, it was aimed to investigate the oxidant-antioxidant balance parameters in individuals with peri ...
Gülbahar Ustaoğlu   +2 more
doaj   +1 more source

PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos. [PDF]

open access: yes, 2012
Animal studies have shown that paraoxonase 1 (PON1) genotype can influence susceptibility to the organophosphorus pesticide chlorpyrifos (CPF). However, Monte Carlo analysis suggests that PON1 genotype may not affect CPF-related toxicity at low exposure ...
Bonner, Matthew R   +6 more
core   +1 more source

Distribution of Paraoxonase 1 polymorphisms and activities in obese patients

open access: yesRomanian Journal of Laboratory Medicine, 2013
Obiectivul studiului a fost de investigarea fenotipului şi genotipului PON1 la pacienţii români cu obezitate abdominală. Material şi metodă. Loturile din studiu au constat din 88 de pacienţi cu obezitate abdominală şi 46 subiecţi cu circumferinţă ...
Ciumărnean Lorena   +6 more
doaj   +1 more source

Relationship of High-Density Lipoprotein-Associated Arylesterase Activity to Systolic Heart Failure in Patients with and without Type 2 Diabetes

open access: yesScientific Reports, 2019
High-density lipoprotein (HDL) confers protection against cardiovascular disease partly attributable to its robust anti-oxidant activities, which is largely impaired in diabetic conditions.
Chang Li   +9 more
semanticscholar   +1 more source

Association of Serum Paraoxonase/Arylesterase Activity with All-Cause Mortality in Maintenance Hemodialysis Patients.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2019
CONTEXT In end-stage renal disease (ESRD), serum high-density lipoprotein cholesterol (HDL-C) level is not an accurate predictor of mortality, partly because it does not necessarily correlate with indices of HDL function.
Yasunori Suematsu   +12 more
semanticscholar   +1 more source

Study of Oxidative Stress Marker Serum Paraoxonase in Metabolic Syndrome

open access: yesEndocrinology Research and Practice, 2016
Purpose: The metabolic syndrome (MetS) is a constellation of interrelated risk factors of metabolic origin that appear to promote development of cardiovascular disease.
Mohit Rojekar   +2 more
doaj   +1 more source

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis

open access: yesMolecules, 2021
Oxidative stress is involved in the pathophysiology of nonalcoholic fatty liver disease (NAFLD). However, reliable biomarkers of NAFLD in relation to oxidative stress are not available.
Kazuhiko Kotani   +3 more
doaj   +1 more source

Sleepiness, inflammation and oxidative stress markers in middle-aged males with obstructive sleep apnea without metabolic syndrome: a cross-sectional study [PDF]

open access: yes, 2015
Background: the simultaneous occurrence of metabolic syndrome and excessive daytime sleepiness are very common in obstructive sleep apnea (OSA) patients.
Andaku, Daniela Kuguimoto   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy